Paul Rozance
Concepts (366)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 77 | 2026 | 880 | 7.690 |
Why?
| | Fetus | 49 | 2026 | 803 | 7.400 |
Why?
| | Hypoglycemia | 29 | 2024 | 477 | 6.840 |
Why?
| | Glucose | 48 | 2026 | 1047 | 6.830 |
Why?
| | Fetal Growth Retardation | 55 | 2025 | 587 | 6.630 |
Why?
| | Insulin | 46 | 2026 | 2507 | 4.990 |
Why?
| | Placental Insufficiency | 22 | 2025 | 125 | 4.860 |
Why?
| | Amino Acids | 21 | 2026 | 521 | 4.180 |
Why?
| | Blood Glucose | 35 | 2026 | 2327 | 3.480 |
Why?
| | Glucagon | 11 | 2026 | 112 | 3.430 |
Why?
| | Islets of Langerhans | 13 | 2024 | 833 | 3.290 |
Why?
| | Insulin-Secreting Cells | 14 | 2024 | 388 | 3.240 |
Why?
| | Pregnancy | 92 | 2026 | 7190 | 3.000 |
Why?
| | Insulin-Like Growth Factor I | 9 | 2024 | 319 | 2.910 |
Why?
| | Liver | 21 | 2026 | 1887 | 2.880 |
Why?
| | Placenta | 17 | 2026 | 780 | 2.840 |
Why?
| | Fetal Development | 17 | 2024 | 299 | 2.380 |
Why?
| | Pancreas | 14 | 2024 | 341 | 2.140 |
Why?
| | Hyperinsulinism | 7 | 2020 | 113 | 1.990 |
Why?
| | Leucine | 8 | 2022 | 116 | 1.930 |
Why?
| | Gluconeogenesis | 9 | 2026 | 83 | 1.870 |
Why?
| | Hyperglycemia | 7 | 2021 | 375 | 1.820 |
Why?
| | Infant, Newborn, Diseases | 5 | 2019 | 113 | 1.650 |
Why?
| | Infant, Premature | 8 | 2024 | 611 | 1.640 |
Why?
| | Maternal-Fetal Exchange | 7 | 2024 | 169 | 1.490 |
Why?
| | Animals | 90 | 2026 | 38058 | 1.480 |
Why?
| | Muscle, Skeletal | 16 | 2025 | 1795 | 1.350 |
Why?
| | Fetal Blood | 10 | 2024 | 342 | 1.300 |
Why?
| | Myoblasts | 3 | 2021 | 84 | 1.240 |
Why?
| | Infant, Newborn | 25 | 2024 | 6429 | 1.190 |
Why?
| | Female | 103 | 2026 | 78271 | 1.180 |
Why?
| | Monitoring, Physiologic | 3 | 2018 | 289 | 1.120 |
Why?
| | Cell Proliferation | 6 | 2024 | 2496 | 1.110 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 56 | 1.110 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2024 | 279 | 1.110 |
Why?
| | Gestational Age | 15 | 2025 | 975 | 1.100 |
Why?
| | Hypoxia | 6 | 2021 | 1199 | 1.080 |
Why?
| | Placental Lactogen | 6 | 2024 | 17 | 0.940 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 26 | 0.940 |
Why?
| | Hepatocyte Growth Factor | 2 | 2016 | 33 | 0.900 |
Why?
| | Metformin | 2 | 2024 | 318 | 0.790 |
Why?
| | RNA Interference | 6 | 2026 | 476 | 0.790 |
Why?
| | Hypoglycemic Agents | 7 | 2024 | 1387 | 0.760 |
Why?
| | Diabetes, Gestational | 3 | 2022 | 321 | 0.740 |
Why?
| | Hindlimb | 3 | 2021 | 131 | 0.710 |
Why?
| | Streptozocin | 1 | 2021 | 21 | 0.690 |
Why?
| | Muscle Proteins | 3 | 2022 | 244 | 0.670 |
Why?
| | Signal Transduction | 9 | 2021 | 5226 | 0.660 |
Why?
| | NF-kappa B | 2 | 2021 | 661 | 0.650 |
Why?
| | Caloric Restriction | 2 | 2024 | 127 | 0.620 |
Why?
| | Oxygen | 13 | 2024 | 995 | 0.590 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 73 | 0.550 |
Why?
| | Anemia | 2 | 2017 | 188 | 0.540 |
Why?
| | Catecholamines | 2 | 2017 | 87 | 0.520 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2016 | 30 | 0.520 |
Why?
| | Surface-Active Agents | 1 | 2017 | 92 | 0.510 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.480 |
Why?
| | Respiratory System | 1 | 2017 | 149 | 0.480 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2016 | 55 | 0.470 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 779 | 0.470 |
Why?
| | Oxidation-Reduction | 8 | 2024 | 1087 | 0.460 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 458 | 0.460 |
Why?
| | Developmental Disabilities | 2 | 2015 | 281 | 0.460 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2016 | 557 | 0.460 |
Why?
| | Sweetening Agents | 1 | 2015 | 57 | 0.450 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2021 | 699 | 0.450 |
Why?
| | Lactic Acid | 8 | 2024 | 302 | 0.450 |
Why?
| | RNA, Messenger | 7 | 2022 | 2832 | 0.450 |
Why?
| | Postpartum Period | 1 | 2018 | 365 | 0.450 |
Why?
| | Infant, Small for Gestational Age | 2 | 2018 | 109 | 0.440 |
Why?
| | Diazoxide | 3 | 2024 | 21 | 0.440 |
Why?
| | Disease Models, Animal | 16 | 2025 | 4557 | 0.440 |
Why?
| | Acidosis | 2 | 2020 | 105 | 0.410 |
Why?
| | Uterus | 5 | 2022 | 226 | 0.410 |
Why?
| | Humans | 45 | 2024 | 144759 | 0.410 |
Why?
| | Placental Circulation | 3 | 2021 | 70 | 0.400 |
Why?
| | Pregnancy Complications | 3 | 2019 | 592 | 0.390 |
Why?
| | Endothelial Cells | 3 | 2018 | 869 | 0.380 |
Why?
| | Periodicals as Topic | 2 | 2017 | 203 | 0.370 |
Why?
| | Hepatocytes | 5 | 2024 | 223 | 0.370 |
Why?
| | Stress, Physiological | 1 | 2016 | 453 | 0.370 |
Why?
| | Glucose Clamp Technique | 5 | 2020 | 199 | 0.370 |
Why?
| | Organ Size | 7 | 2021 | 463 | 0.360 |
Why?
| | Random Allocation | 7 | 2012 | 363 | 0.360 |
Why?
| | Muscle Development | 3 | 2021 | 116 | 0.350 |
Why?
| | Malnutrition | 1 | 2012 | 86 | 0.350 |
Why?
| | Glucose Transporter Type 3 | 3 | 2026 | 15 | 0.340 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2024 | 2583 | 0.320 |
Why?
| | Dietary Supplements | 3 | 2012 | 576 | 0.320 |
Why?
| | Pulmonary Artery | 2 | 2018 | 1134 | 0.310 |
Why?
| | Male | 27 | 2024 | 72315 | 0.310 |
Why?
| | Insulins | 2 | 2022 | 38 | 0.310 |
Why?
| | Dietary Proteins | 1 | 2011 | 136 | 0.300 |
Why?
| | Insulin Resistance | 7 | 2019 | 1241 | 0.290 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 13 | 0.290 |
Why?
| | Pulmonary Alveoli | 1 | 2011 | 383 | 0.290 |
Why?
| | Infant | 9 | 2023 | 10034 | 0.270 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 145 | 0.270 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 214 | 0.260 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2608 | 0.260 |
Why?
| | Fetal Diseases | 3 | 2021 | 191 | 0.260 |
Why?
| | Infusion Pumps | 2 | 2021 | 32 | 0.250 |
Why?
| | Arginine | 5 | 2026 | 262 | 0.250 |
Why?
| | Down-Regulation | 3 | 2017 | 627 | 0.250 |
Why?
| | Fetal Macrosomia | 2 | 2021 | 62 | 0.240 |
Why?
| | Amino Acids, Essential | 1 | 2006 | 13 | 0.240 |
Why?
| | Up-Regulation | 4 | 2017 | 851 | 0.240 |
Why?
| | History, 20th Century | 3 | 2017 | 325 | 0.230 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2025 | 23 | 0.230 |
Why?
| | Glucose-6-Phosphatase | 4 | 2016 | 31 | 0.230 |
Why?
| | Infusions, Intravenous | 5 | 2024 | 423 | 0.230 |
Why?
| | Sheep, Domestic | 6 | 2019 | 33 | 0.220 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 26 | 0.220 |
Why?
| | Breast Feeding | 2 | 2019 | 448 | 0.220 |
Why?
| | Capillaries | 1 | 2025 | 124 | 0.210 |
Why?
| | Pediatrics | 5 | 2018 | 1114 | 0.210 |
Why?
| | Neonatologists | 1 | 2024 | 9 | 0.210 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2024 | 675 | 0.210 |
Why?
| | Fetal Heart | 1 | 2024 | 57 | 0.200 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 102 | 0.200 |
Why?
| | Norepinephrine | 4 | 2020 | 196 | 0.200 |
Why?
| | Lipid Metabolism | 3 | 2024 | 527 | 0.190 |
Why?
| | Chronic Disease | 4 | 2017 | 1813 | 0.190 |
Why?
| | Hydrocortisone | 5 | 2020 | 304 | 0.190 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 570 | 0.190 |
Why?
| | Nervous System Diseases | 1 | 2006 | 284 | 0.190 |
Why?
| | Carbohydrates | 1 | 2022 | 66 | 0.190 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2020 | 24 | 0.180 |
Why?
| | Fetal Weight | 3 | 2022 | 54 | 0.180 |
Why?
| | Glycogen | 3 | 2020 | 54 | 0.180 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.180 |
Why?
| | Diet, High-Fat | 2 | 2023 | 261 | 0.180 |
Why?
| | Carotid Arteries | 2 | 2013 | 207 | 0.170 |
Why?
| | Insulinoma | 1 | 2021 | 28 | 0.170 |
Why?
| | Oxygen Consumption | 2 | 2024 | 724 | 0.170 |
Why?
| | Chemokine CXCL10 | 1 | 2021 | 39 | 0.170 |
Why?
| | I-kappa B Kinase | 1 | 2021 | 51 | 0.170 |
Why?
| | Feces | 1 | 2024 | 513 | 0.170 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2021 | 162 | 0.170 |
Why?
| | Endotoxemia | 1 | 2021 | 87 | 0.160 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 66 | 0.160 |
Why?
| | Biosensing Techniques | 2 | 2014 | 139 | 0.160 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 70 | 0.160 |
Why?
| | Gene Silencing | 1 | 2021 | 205 | 0.160 |
Why?
| | Chorioamnionitis | 1 | 2020 | 45 | 0.150 |
Why?
| | Energy Intake | 1 | 2022 | 499 | 0.150 |
Why?
| | Transcriptome | 2 | 2024 | 1045 | 0.150 |
Why?
| | Drug Synergism | 1 | 2020 | 357 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2021 | 198 | 0.150 |
Why?
| | Receptor, Insulin | 2 | 2011 | 94 | 0.150 |
Why?
| | Transcription Factors | 1 | 2007 | 1741 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2019 | 181 | 0.140 |
Why?
| | Extracellular Matrix | 2 | 2013 | 553 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 983 | 0.140 |
Why?
| | Phosphorylation | 3 | 2019 | 1732 | 0.140 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2018 | 22 | 0.140 |
Why?
| | Vascular Stiffness | 2 | 2013 | 486 | 0.140 |
Why?
| | Cell Survival | 1 | 2021 | 1098 | 0.130 |
Why?
| | Transcription Factor RelA | 1 | 2018 | 85 | 0.130 |
Why?
| | Cell Count | 1 | 2018 | 320 | 0.130 |
Why?
| | Umbilical Cord | 2 | 2016 | 91 | 0.130 |
Why?
| | Neonatology | 1 | 2018 | 28 | 0.130 |
Why?
| | Infant, Extremely Premature | 1 | 2018 | 67 | 0.130 |
Why?
| | Overnutrition | 1 | 2017 | 30 | 0.130 |
Why?
| | Adipose Tissue | 1 | 2021 | 652 | 0.130 |
Why?
| | Infant Formula | 1 | 2017 | 71 | 0.130 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2024 | 905 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 436 | 0.120 |
Why?
| | Arteries | 1 | 2018 | 259 | 0.120 |
Why?
| | Enteral Nutrition | 1 | 2019 | 216 | 0.120 |
Why?
| | Energy Metabolism | 2 | 2021 | 935 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 771 | 0.120 |
Why?
| | Time Factors | 4 | 2012 | 7173 | 0.120 |
Why?
| | Calcium | 1 | 2022 | 1183 | 0.120 |
Why?
| | Blotting, Western | 4 | 2019 | 1187 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1217 | 0.120 |
Why?
| | Hemodynamics | 1 | 2021 | 1121 | 0.120 |
Why?
| | Potassium Chloride | 2 | 2014 | 40 | 0.120 |
Why?
| | Treatment Failure | 1 | 2017 | 365 | 0.120 |
Why?
| | Ultrasonography, Prenatal | 1 | 2018 | 294 | 0.120 |
Why?
| | Linear Models | 1 | 2018 | 854 | 0.110 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2012 | 39 | 0.110 |
Why?
| | Lower Extremity | 1 | 2019 | 438 | 0.110 |
Why?
| | Biomedical Research | 1 | 2022 | 710 | 0.110 |
Why?
| | Cell Division | 1 | 2017 | 766 | 0.110 |
Why?
| | Parenteral Nutrition | 1 | 2016 | 105 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1356 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Nurseries, Hospital | 1 | 2014 | 5 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1047 | 0.100 |
Why?
| | Hydrochlorothiazide | 1 | 2014 | 7 | 0.100 |
Why?
| | Endocrinology | 1 | 2015 | 77 | 0.100 |
Why?
| | Homeostasis | 1 | 2018 | 640 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2021 | 3121 | 0.100 |
Why?
| | Diuretics | 1 | 2014 | 68 | 0.100 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 52 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5992 | 0.100 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 6 | 0.100 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 3540 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2016 | 478 | 0.100 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 52 | 0.100 |
Why?
| | Mice | 5 | 2024 | 18339 | 0.090 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2018 | 410 | 0.090 |
Why?
| | Pyruvic Acid | 2 | 2024 | 55 | 0.090 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.090 |
Why?
| | Cell Size | 1 | 2012 | 92 | 0.090 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2012 | 15 | 0.090 |
Why?
| | Solutions | 1 | 2012 | 166 | 0.090 |
Why?
| | Umbilical Arteries | 1 | 2012 | 52 | 0.090 |
Why?
| | Macrophages | 1 | 2020 | 1511 | 0.090 |
Why?
| | Premature Birth | 1 | 2016 | 380 | 0.090 |
Why?
| | Hyperplasia | 1 | 2012 | 174 | 0.090 |
Why?
| | Hernia, Diaphragmatic | 1 | 2012 | 67 | 0.090 |
Why?
| | Heart | 1 | 2016 | 636 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2014 | 331 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 190 | 0.090 |
Why?
| | Cell Aggregation | 1 | 2011 | 19 | 0.090 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 195 | 0.090 |
Why?
| | Intestinal Obstruction | 1 | 2012 | 56 | 0.090 |
Why?
| | Mitosis | 1 | 2012 | 200 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 85 | 0.090 |
Why?
| | Infant Nutrition Disorders | 1 | 2011 | 10 | 0.090 |
Why?
| | Parenteral Nutrition, Total | 1 | 2011 | 30 | 0.080 |
Why?
| | Mammals | 2 | 2023 | 293 | 0.080 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 286 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 6048 | 0.080 |
Why?
| | Primary Cell Culture | 1 | 2011 | 173 | 0.080 |
Why?
| | Carbon Dioxide | 2 | 2012 | 242 | 0.080 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 204 | 0.080 |
Why?
| | Taurine | 1 | 2011 | 41 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 2011 | 247 | 0.080 |
Why?
| | Animals, Newborn | 2 | 2024 | 902 | 0.080 |
Why?
| | Blood Vessels | 1 | 2011 | 171 | 0.080 |
Why?
| | Intensive Care, Neonatal | 1 | 2010 | 42 | 0.080 |
Why?
| | Algorithms | 3 | 2018 | 1837 | 0.080 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2011 | 149 | 0.070 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 41 | 0.070 |
Why?
| | Gene Expression | 2 | 2011 | 1490 | 0.070 |
Why?
| | Apoptosis | 2 | 2019 | 2430 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2878 | 0.070 |
Why?
| | Prevalence | 1 | 2016 | 2834 | 0.070 |
Why?
| | Glycine | 2 | 2023 | 187 | 0.070 |
Why?
| | Guidelines as Topic | 1 | 2010 | 267 | 0.070 |
Why?
| | Liver Glycogen | 1 | 2007 | 15 | 0.070 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 22 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 2 | 2020 | 8 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 561 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1716 | 0.060 |
Why?
| | Cohort Studies | 1 | 2018 | 5960 | 0.060 |
Why?
| | Biological Transport | 2 | 2020 | 417 | 0.060 |
Why?
| | Cell Movement | 1 | 2011 | 965 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2007 | 540 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2011 | 897 | 0.060 |
Why?
| | Lysine | 1 | 2009 | 302 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2007 | 415 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5868 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1021 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 863 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1782 | 0.050 |
Why?
| | Citrate (si)-Synthase | 1 | 2024 | 57 | 0.050 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 232 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 107 | 0.050 |
Why?
| | Adult | 3 | 2023 | 40449 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2011 | 4154 | 0.050 |
Why?
| | Risk Factors | 2 | 2016 | 10779 | 0.050 |
Why?
| | Societies, Medical | 2 | 2020 | 887 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Elastin | 2 | 2013 | 79 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 210 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 74 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2022 | 5 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.050 |
Why?
| | Ruminants | 1 | 2022 | 7 | 0.050 |
Why?
| | Glucose Transporter Type 1 | 1 | 2022 | 48 | 0.050 |
Why?
| | Serine | 1 | 2023 | 145 | 0.050 |
Why?
| | Birth Weight | 2 | 2018 | 522 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2022 | 53 | 0.050 |
Why?
| | Blastocyst | 1 | 2021 | 47 | 0.040 |
Why?
| | Phosphates | 1 | 2022 | 180 | 0.040 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 41 | 0.040 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 32 | 0.040 |
Why?
| | Placentation | 1 | 2021 | 53 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2021 | 126 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2017 | 11679 | 0.040 |
Why?
| | Collagen | 2 | 2013 | 456 | 0.040 |
Why?
| | Astrocytoma | 1 | 2001 | 129 | 0.040 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 79 | 0.040 |
Why?
| | Research Personnel | 1 | 2022 | 186 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2027 | 0.040 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 43 | 0.040 |
Why?
| | Weight Gain | 1 | 2023 | 556 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 219 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 339 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 413 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 162 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 635 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 197 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 400 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 171 | 0.040 |
Why?
| | Lung | 1 | 2011 | 4109 | 0.030 |
Why?
| | Body Weight | 2 | 2012 | 976 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2012 | 307 | 0.030 |
Why?
| | Term Birth | 1 | 2016 | 25 | 0.030 |
Why?
| | Temperature | 1 | 2019 | 679 | 0.030 |
Why?
| | Delphi Technique | 1 | 2018 | 329 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 488 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2008 | 514 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 83 | 0.030 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2016 | 106 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 29 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 392 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 846 | 0.030 |
Why?
| | Compliance | 1 | 2012 | 49 | 0.020 |
Why?
| | Blood Transfusion | 1 | 2016 | 405 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2012 | 164 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 251 | 0.020 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 28 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 26 | 0.020 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 24 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 153 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 83 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 370 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 119 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 144 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 173 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 202 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2012 | 327 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 134 | 0.020 |
Why?
| | Diseases in Twins | 1 | 2012 | 115 | 0.020 |
Why?
| | Stimulation, Chemical | 1 | 2011 | 53 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 416 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 341 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 939 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2012 | 230 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 757 | 0.020 |
Why?
| | Trans-Activators | 1 | 2012 | 405 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 27 | 0.020 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2012 | 219 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 45 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 24 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 32 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 51 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1627 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 326 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 138 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1560 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 523 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 307 | 0.020 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2007 | 16 | 0.020 |
Why?
| | Child | 2 | 2020 | 22633 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4271 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 315 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1769 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2011 | 790 | 0.010 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 449 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 229 | 0.010 |
Why?
| | United States | 1 | 2022 | 15966 | 0.010 |
Why?
| | Hypertension | 1 | 2012 | 1263 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 31 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5597 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1821 | 0.010 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 79 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11787 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 3077 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 3863 | 0.000 |
Why?
|
|
Rozance's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|